Neuroprotective Effect of Butylphthalide for Cardiac Arrest Patients

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 350 participants.

Also called NCT06572085

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 350 participants (planned count) (from the registry)
Sponsor
Tang Ziren (from the registry)
Registry
  • NCT NCT06572085
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06572085. Randomized; quadruple masking; primary purpose treatment. Start 2022-01-01 (actual); primary completion 2027-12-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Neuroprotective Effect of Butylphthalide for Cardiac Arrest Patients
Condition
Butylphthalide
Condition
Neuroprotective Drugs
Intervention (Drug)
Butylphthalide and Sodium Chloride Injection
Intervention (Drug)
Saline Solution
Lead sponsor
Tang Ziren (class: other)

Record details

Record id
cardio:ct-nct06572085
Content hash
da292a21085dcdc621b65bfe45bcb9431707ddec63ccab8506827cf94cc64a2a